U.S. Commercial Services Stock News

Fulcrum Therapeutics (FULC) is in the spotlight after halting development of its sickle cell drug pociredir, following FDA concerns about malignancy risks with PRC2 inhibitors and launching a broad review of future options. See our latest analysis for Fulcrum Therapeutics. The recent pociredir halt and review of future options have coincided with intense selling pressure, with the 7 day share price return down 52.5% and the year to date share price return down 70.5%. The 3 year total...

Wondering whether J.B. Hunt Transport Services at US$283.31 is offering good value or asking too much of future expectations? This article breaks down what the current price might be implying. The stock has returned 4.0% over the past week, 16.6% over the past month, 44.0% year to date and 105.6% over the past year, which raises fair questions about how much optimism is already in the price. Recent coverage has focused on J.B. Hunt Transport Services as part of broader discussions around...

Ciena (CIEN) has just posted Q2 2026 results with revenue of US$1.6b and basic EPS of US$1.54, set against trailing twelve month revenue of US$5.6b and basic EPS of US$3.09 that reflect earnings growth of 319.4% over the past year. The company has seen quarterly revenue move from US$1.1b in Q2 2025 to US$1.6b in Q2 2026, while basic EPS over the same quarters shifted from US$0.06 to US$1.54, and trailing net profit margin now sits at 7.9% compared with 2.5% a year earlier. This frames a set...

Intapp (INTA) has drawn fresh attention after signing Ropes & Gray and Arkwright Consulting to its DealCloud platform, alongside a new AI powered release of Intapp Time aimed at time capture and compliance workflows. See our latest analysis for Intapp. These client wins and AI product updates arrive as the stock trades at US$24.39, with a 7 day share price return of 18.4% contrasting with a year to date share price decline of 44.4% and a 1 year total shareholder return that is down 56.9%...

Petco Health and Wellness Company (WOOF) opened Q1 2027 with revenue of US$1.5 billion, a basic EPS loss of US$0.05, and a net loss of US$15.1 million, while same store sales in the quarter grew 0.7%. Over recent periods the company has seen quarterly revenue move around the US$1.5 billion mark, with basic EPS ranging from a profit of US$0.05 in Q2 2026 to losses such as US$0.04 in Q1 2026 as margins and earnings quality shifted. In that context, and given expectations for stronger earnings...

Jade Biosciences stock reaction Jade Biosciences (JBIO) has attracted fresh attention after recent share price swings, including a move higher in the latest session while remaining down over the past week and month but up over the past 3 months. See our latest analysis for Jade Biosciences. At the current share price of $17.74, Jade Biosciences has a 1 day share price return of 0.85%, a 30 day share price return down 29.77%, and a 1 year total shareholder return of 157.47%, indicating...

Teekay Tankers (NYSE:TNK) has been recognized as one of the most efficient companies in its industry. The company was highlighted for outperforming peers in inventory management, receivables, asset utilization, and profit margins. Its ship to ship transfer and lightering operations were specifically called out as standouts within the sector. For anyone tracking oil and product shipping, this kind of operational spotlight on Teekay Tankers (NYSE:TNK) is material. The company runs crude and...

ZenaTech (NasdaqCM:ZENA) is moving into the defense technology sector with counter unmanned aerial systems interceptor drones. The company is expanding its operations through acquisitions of land survey and legacy service businesses. ZenaTech has acquired a stake in Plurilock Security and is pursuing collaborations and investment opportunities with U.S. defense agencies. ZenaTech is shifting its focus beyond its core Drone as a Service operations as the stock trades around $1.52. The share...

Oscar Health (NYSE:OSCR) co founder and former CTO Mario Schlosser is shifting into an advisory role focused on AI and digital health. The leadership change has raised questions among investors about product direction and continuity of Oscar's technology platform. Schlosser will remain on the Board and continue to shape Oscar's AI and digital health agenda. Oscar Health's stock recently closed at $20.50, with the move coinciding with a share price reaction and a return of down 6.8% over the...

WhiteFiber (NasdaqCM: WYFI) has signed a five year, $160m AI compute infrastructure contract in the Paris region, using NVIDIA GPUs for an investment grade customer. The company has also arranged a $100m delayed draw term loan with Bit Digital, secured by Ethereum backed assets. Both agreements are structured with prepayments and project specific funding intended to limit balance sheet exposure as service begins. For investors tracking WhiteFiber at a share price of $28.03, the stock has...

Why Oddity Tech’s latest earnings and outlook matter for investors Oddity Tech (ODD) recently reported a swing from profit to net loss alongside lower first quarter sales, and guided to a 25% to 30% year-over-year net revenue decline for the second quarter. This combination of weaker recent results and cautious guidance has sharpened investor focus on Oddity Tech’s growth profile, profitability path, and how the stock’s sharp pullback over the past month and past 3 months fits into the...

MaxLinear (NasdaqGS:MXL) and Los Alamos National Laboratory are collaborating on hardware accelerated OpenZFS storage for high performance computing environments. The project integrates MaxLinear Panther SoCs with OpenZFS to offload compute intensive ZFS operations and support higher throughput and scalability for large scale storage. This marks an expansion of MaxLinear’s role in AI driven data infrastructure and scientific computing, beyond its previously highlighted AI and connectivity...

If you are wondering whether Hormel Foods at around US$23.13 is a bargain or a value trap right now, this article walks through the key numbers that matter for you as a shareholder or prospective investor. The stock has rebounded recently, with a 10.4% gain over the past week and 12.0% over the past month, but is still down 1.1% year to date and has declined 20.9% over the last year, 35.5% over three years, and 43.6% over five years. Recent coverage has focused on how the company is handling...

GigaCloud Technology, ticker NasdaqGM:GCT, has been included on TIME's World’s Growth Leaders 2026 list. The company also received multiple Gold Stevie Awards at the 2026 American Business Awards for ecommerce, company growth, and innovation. For investors tracking NasdaqGM:GCT, this recognition comes as the stock trades around $32.41, with the share price up 74.3% over the past year and showing very large gains over three years. At the same time, the stock is down 15.5% over the past week,...

Why ZoomInfo Technologies (GTM) Is Back on Investors’ Radar ZoomInfo Technologies (GTM) has drawn attention after a steep share price decline, with the stock down 52% over the past month and 53% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for ZoomInfo Technologies. At a share price of US$3.12, ZoomInfo’s momentum has clearly faded, with the stock’s share price return falling 52.2% over 30 days and its 1 year total shareholder return declining...

Liberty Energy (LBRT) just posted first quarter 2026 results that topped Wall Street forecasts on both revenue and earnings, with management highlighting strong demand for its premium fleet and StimCommander that currently exceeds available deployment capacity. See our latest analysis for Liberty Energy. Despite the strong Q1 beat and tight premium fleet capacity, Liberty Energy’s share price has cooled in the past month, with an 8.5% decline over 30 days. However, the 64.5% year to date...

Aflac recently reported strong first-quarter 2026 results, highlighting solid revenue, sustained profitability, and returning about US$1.00 billion to shareholders through dividends and share repurchases. Alongside this, Aflac’s recognition of Dr. Heather Bittner Fagan as an Aflac Check for Cancer Champion underscores the company’s emphasis on cancer prevention and screening, reinforcing the relevance of its supplemental health products. Next, we’ll examine how Aflac’s robust earnings and...

Central Securities (CET) offers investors a closed end fund focused on US securities. Shares recently closed at US$52.70 and the fund has a market value around US$1.6b, inviting closer attention to its valuation profile. See our latest analysis for Central Securities. Recent trading has been slightly softer, with the share price down over the past month but still showing a positive 90 day share price return of 2.33% and a 1 year total shareholder return of 19.12%. This points to momentum that...

Nvidia, Siemens, and nVent Electric (NYSE:NVT) released a blueprint for 100-megawatt AI data centers, highlighting nVent’s liquid cooling and plumbing hardware as key infrastructure. The design targets next generation AI facilities that require high power density and advanced thermal management. This partnership positions nVent directly inside the core buildout plans for large scale AI computing projects. For investors who have watched NYSE:NVT, the story has recently centered on buybacks,...

KULR Technology Group recently announced it entered into a prototype development and fabrication agreement with a U.S.-based defense drone manufacturer to design, test, and qualify lithium-ion battery packs for unmanned aerial vehicles and handheld controllers, while also advancing next-generation drone battery pack integration using Factorial Inc.’s solid-state and lithium-metal cells. Together, these collaborations deepen KULR’s role in mission-critical unmanned systems by pairing its KULR...

If you are wondering whether Rocket Companies stock is priced attractively today, the starting point is understanding how its current share price lines up against several valuation checks. The stock closed at US$12.94, with the share price down 9.3% over the past week, 7.6% over the past month and 34.9% year to date, while still showing a 3.8% gain over the last year and a 59.7% gain over three years, but down 32.3% over five years. Recent coverage around Rocket Companies has focused on its...

Klaviyo recently reported strong Q1 2026 results, with 28% year-over-year revenue growth, its best operating margin since listing, a larger customer base of more than 196,000 accounts, and a newly authorized US$500.00 million share repurchase program. The company also raised its full-year 2026 revenue guidance while emphasizing deeper AI integration across its platform, underscoring management’s focus on AI-enabled expansion and capital returns even as it prepares for a CFO transition later...

Wondering if Flywire's current share price around US$14.61 still leaves room for value, or if most of the upside is already priced in. The stock is down 7.6% over the past week but up 2.7% over the last month, 5.1% year to date, and 46.1% over the past year, which can change how you think about both its potential and its risk. These moves come after a period where investors have been reassessing high growth payment and financial technology stocks. There has been attention on business models...

AnaptysBio (NasdaqGS:ANAB) has approved a change in its fiscal year-end from December 31 to June 30. The new fiscal year-end is expected to affect the timing of future financial reports and corporate disclosures. The decision reflects an adjustment to the company’s reporting calendar and financial planning framework. AnaptysBio, trading at $51.24, has recorded very large share price gains over the past year, with the stock up 261.4% over that period and 220.2% over five years. The...